Invasive aspergillosis in glucocorticoid-treated patients
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Glucocorticoids have potent, pleiotropic effects on the immune system that can predispose patients to developing life-threatening invasive aspergillosis (IA). While the exact prevalence and attributable mortality of IA in glucocorticoid-treated patients is difficult to estimate, Aspergillus species are significant pathogens in patients that require prolonged high-dose glucocorticoid therapy including multiple myeloma, collagen vascular diseases, or recipients of solid organ/hematopoietic transplantation. Experimental animal models and autopsy series have revealed important differences in the pathology of aspergillosis between glucocorticoid-treated and neutropenic patients. Although neutropenic hosts develop infection characterized by extensive angioinvasion, hemorrhagic thrombosis and necrosis with a high fungal burden, glucocorticoid-immunosuppressed hosts present with infection dominated by extensive necrosis, less angioinvasion, and a lower fungal burden suggestive of an inflammation-driven pathology. These pathobiological differences may have important implications for the diagnosis and treatment approaches of IA in glucocorticoid-treated patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 9×
“The effects of glucocorticoids on B-cells are mediated in part by reduction T-helper cell interactions required for antibody production [ 2 ].”
BackgroundInfluentialNeutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 3×
“While NF-kB activation in neutrophils at the onset of infection is required for pro-inflammatory gene expression, the activation of this transcription factor later in the inflammatory response is also critical for expression of genes controlling inflammation (i.e., IL-10), recruitment of Treg cells (IL-4), and inducti…”
BackgroundInfluentialRomani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Dectin-1: a signalling non-TLR pattern-recognition receptor
Brown, G. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1745 · Cited by 1,158 · cited 1×
“responses that include the release of TNF-a and IL-12, neutrophil chemoattractants, and ROIs [ 83 ].”
BackgroundMarr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Angiopoietins: a link between angiogenesis and inflammation
Fiedler, U., & Augustin, H. G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.004 · Cited by 606
Aspergillus fumigatus Triggers Inflammatory Responses by Stage-Specific β-Glucan Display
Hohl, T. M., Van Epps, H. L., Rivera, A., Morgan, L. A., Chen, P. L., Feldmesser, M., & Pamer, E. G. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010030 · Cited by 428
Aspergillus fumigatus : Principles of Pathogenesis and Host Defense
Hohl, T. M., & Feldmesser, M. (2007) · Eukaryotic Cell · doi:10.1128/ec.00274-07 · Cited by 237
Balloy, V., Huerre, M., Latgé, J.-P., & Chignard, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.494-503.2005 · Cited by 231
Gliotoxin Production in Aspergillus fumigatus Contributes to Host‐Specific Differences in Virulence
Spikes, S., Xu, R., Nguyen, C. K., Chamilos, G., Kontoyiannis, D. P., Jacobson, R. H., Ejzykowicz, D. E., Chiang, L. Y., Filler, S. G., & May, G. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/525044 · Cited by 186
Self-citation
Cited by
Koehler, P., Bassetti, M., Chakrabarti, A., Chen, S. C. A., Colombo, A. L., Hoenigl, M., Klimko, N., Lass-Flörl, C., Oladele, R. O., Vinh, D. C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30847-1 · Cited by 951
Bartoletti, M., Pascale, R., Cricca, M., Rinaldi, M., Maccaro, A., Bussini, L., Fornaro, G., Tonetti, T., Pizzilli, G., Francalanci, E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1065 · Cited by 473
Self-citationCaffrey, A. K., Lehmann, M. M., Zickovich, J. M., Espinosa, V., Shepardson, K. M., Watschke, C. P., Hilmer, K. M., Thammahong, A., Barker, B. M., Rivera, A., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004625 · Cited by 132
“It is wel defined that prolonged corticosteroid treatment increases susceptibility of hosts to IPA [74].”
Fleck, C. B., Schöbel, F., & Brock, M. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.04.007 · Cited by 110
“However, the residual immune system in these patients still attacks fungal pathogens, which may, e.g. cause hyperinflammatory responses (Lewis and Kontoyiannis, 2009).”
BackgroundAn update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections
Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2267977 · Cited by 61
“…increasing number of hematopoietic stem cell transplants (HSCT) [4–8], solid organ transplants (SOT) [9], and individuals receiving systemic immunosuppressive drugs and immunomodulatory therapies such as glucocorticoids [10], TNF-α blockers and small-molecule inhibitors such as ibrutinib [11,12].”
Background
Metadata
- Authors
- Lewis, R. E., & Kontoyiannis, D. P.
- Venue
- Medical Mycology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01
- Volume
- 47
- Issue
- s1
- Pages
- S271-S281
- ISSN
- 0268-1218 (ISSN-L)
- 1369-3786
- 1460-2709
- OpenAlex
- W2158538315
- Cited by
- 113
- References
- 15
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Invasive aspergillosis in glucocorticoid-treated patients. https://app.cochat.ai/papers/10.1080/13693780802227159
- The paper
- Lewis, R. E., & Kontoyiannis, D. P. (2009). Invasive aspergillosis in glucocorticoid-treated patients. Medical Mycology. https://doi.org/10.1080/13693780802227159
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.